2026 University of Kansas Cancer Center Breast Cancer Year in Review
Learn How to Claim Your Credit
The University of Kansas Cancer Center Breast Cancer Year in Review is a condensed review of new data and advances published throughout the year and presented at key oncology meetings. It gives healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This accredited meeting is hosted as an in-person conference only with on-demand access for registered attendees
Event Page
Accreditation Information | 4.00
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior
-
Total Health Conferences
2026 University of Kansas Cancer Center Breast Cancer Year in Review
February 21, 2026
Kansas City, MO
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. If you need MOC credit, you also need to pass a posttest with a score of at least 80%. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
Physicians
Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 4.00 knowledge-based CPE contact hours.
JA4008163-9999-26-061-L01-P | JA4008163-9999-26-061-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.
American Board of Internal Medicine (ABIM) MOC
Successful completion of this CME activity, which includes participation in the evaluation component,
enables the participant to earn up to 4.00 Medical Knowledge MOC points in the American Board of
Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to
submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.
Credits are generally reported during the first week of each month for those who claimed during the month
prior.
Objectives - After Attending This Program You Should Be Able To
1. Determine best application of new targeted therapies in patients with early stage and metastatic disease
2. Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer
3. Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name and Commercial Interest Relationship
Carlos Barcenas: Stemline Menarini, Personalis, Inc., Myriad Genetics: Research Grant Site Principal Investigator
Gaorav Gupta: Naveris, Inc:Private Stock Shareholder, Naveris, Inc:Patent Holder, Naveris, Inc:Scientific/Medical Advisory Board Member
Norah Henry: AstraZeneca: Consultant, Daiichi Sankyo, Genentech: Scientific/Medical Advisory Board Member
Joshua Kra: NA
Erica Mayer: Lilly, Novartis, Genentech/Roche, AstraZeneca: Consultant
Rita Nanda: Astrazeneca, Daiichi Sankyo, Exact Sciences, GE, Gilead, Guardant Health, Merck, Moderna, Novartis, OBI, Pfizer, Sanofi, Seagen, Stemline, Summit Therapeutics: Consultant, Arvinas, AstraZeneca, BMS, Corcept Therapeutics, Genentech/Roche, Gilead, GSK, Merck, Novartis, OBI Pharma, Pfizer, Relay, Seattle Genetics, Sun Pharma, Taiho: Research Grant Site Principal Investigator
Pavan Reddy: NA
Reyna Wilhelm: NA
Justin Kaiser: NA
How to Get Your Certificate
Go to thc.cmecertificateonline.com
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com